Meningitis B Deaths Ignite Vaccine Debate

Two deaths from Meningitis B in Kent have sparked a debate about vaccine availability for teenagers. While babies are vaccinated, older children and young adults may lack protection against this specific strain. Experts discuss the vaccine's effectiveness, carriage, and the ongoing call for wider public health measures.

2 weeks ago
4 min read

Two Deaths Spark Urgent Questions About Meningitis B Vaccine Availability

Two tragic deaths from Meningitis B in Kent have reopened the discussion about vaccine access. The UK Health Security Agency confirmed the outbreak involved the Meningitis B strain. This is a critical point because while babies are routinely vaccinated against Meningitis B, older children and young adults might not be. The vaccine offered to them usually covers other strains.

Understanding Meningitis Strains and Vaccines

Dr. Rosemary Leonard, a general practitioner, explained the current vaccination landscape. “There is a vaccine against meningitis B,” she stated. “It’s given as part of the primary immunizations given to babies.” This is because young babies are most vulnerable to Meningitis B. For older children and teenagers, the main concern is often Meningitis ACWY. A vaccine for this is offered to teenagers in year nine.

The Challenge of Meningitis B Carriage

A key issue with Meningitis B is that it can be carried by people without any symptoms. “It’s thought that about one in four teenagers, young people have the meningitis B strain living in the back of their throat causing them no harm at all,” Dr. Leonard explained. However, for some individuals, this carried bacteria can lead to invasive meningitis and sepsis. Sepsis, a severe reaction to infection, is particularly devastating with Meningitis B.

Vaccine History and Gaps

Meningitis B vaccination for babies only began in 2015. This means teenagers born before 2015 likely did not receive this protection. The Meningitis ACWY vaccine was also introduced in 2015. Dr. Leonard pointed out that even the Meningitis B vaccine has limitations. “There are one several different strains of meningitis B and it doesn’t cover all of them,” she said. Additionally, the vaccine may not be very effective at clearing asymptomatic carriage of the bacteria, unlike the Meningitis ACWY vaccine.

The Debate Over Universal Teen Vaccination

Because of these factors, health officials have not recommended giving the Meningitis B vaccine to all young people. However, the recent deaths may change this thinking. “It will be interesting to see if this awful, awful outbreak alters the debate about whether young people should be given meningitis B vaccine in in addition to the menacwy,” Dr. Leonard commented.

Parental Concerns and Private Vaccination

The current situation leaves many parents with difficult choices. One parent shared their concern: “I have three children. One is 17, one is 14, and one is eight. The 8-year-old will have been given the B vaccine. The other two will not have done.” They questioned whether they should pay for the Meningitis B vaccine privately for their older children. Dr. Leonard noted that private vaccination costs around £100 per dose, meaning about £200 for the full course. She also reminded people that vaccines take time to work, usually at least two weeks.

Campaigning for Change

There is already a campaign pushing for wider Meningitis B vaccination. Meningitis Now, a charity supporting those affected by the disease, has been advocating for years. They argue that Meningitis B should be given to teenagers alongside the Meningitis ACWY vaccine. The charity believes this is necessary to protect more young people.

Cost-Effectiveness and Public Health Decisions

Dr. Leonard addressed the practicalities of expanding the vaccine program. “The problem with it is you’ve got to look at the cost effectiveness,” she stated. Vaccinating all teenagers would be very expensive. Public health bodies like NICE must consider if this is the best use of limited health service funds. For families who have suffered from meningitis, the answer is often a clear yes. The recent deaths of two young people highlight the devastating impact of the disease.

Duration of Immunity and Future Questions

Questions remain about how long the Meningitis B vaccine provides protection. “At the moment it’s only given as a primary vaccine,” Dr. Leonard said. “What we don’t know is how long that immunity lasts and whether they are protected lifelong.” Parents who received the vaccine as babies are unsure if they need boosters later in life.

The Role of Vapes in Transmission?

A theory has emerged suggesting vapes could play a role in spreading Meningitis B. This is due to the practice of sharing vapes, particularly in social settings like nightclubs. “Yes, absolutely. It is spread it is spread by droplet,” Dr. Leonard confirmed. “It could be spread by vapes with with saliva on vapes. Yes.” This highlights how easily the bacteria can pass between people.

Moving Forward: Strategy and Communication

The focus now is on ensuring a swift and effective response to outbreaks. Helen Whately, the Conservative MP for the area, stressed the importance of a clear strategy. This includes good communication and protecting those who may have been exposed. The UK Health Security Agency will be providing further information on managing such situations.


Source: Meningitis B Deaths Blow Vaccine Debate Wide Open | Rosemary Leonard (YouTube)

Written by

Joshua D. Ovidiu

I enjoy writing.

10,961 articles published
Leave a Comment